AN UNBIASED VIEW OF RAW MATERIALS

In the same year the ITC also documented on their own initiatives toward the circulation syntheses of two lead compounds reported earlier by AstraZeneca. The 1st a single particulars the flow synthesis of a strong 5HT1B antagonist (28) that was assembled by way of a 5 move constant synthesis which include a SNAr reaction, heterogeneous hydrogenatio